Details for New Drug Application (NDA): 019982
✉ Email this page to a colleague
The generic ingredient in ZEBETA is bisoprolol fumarate. There are twelve drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the bisoprolol fumarate profile page.
Summary for 019982
Tradename: | ZEBETA |
Applicant: | Teva Womens |
Ingredient: | bisoprolol fumarate |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 019982
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jul 31, 1992 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Jul 31, 1992 | TE: | RLD: | Yes |
Expired US Patents for NDA 019982
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Teva Womens | ZEBETA | bisoprolol fumarate | TABLET;ORAL | 019982-002 | Jul 31, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Teva Womens | ZEBETA | bisoprolol fumarate | TABLET;ORAL | 019982-001 | Jul 31, 1992 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription